These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16469536)

  • 1. Tei index and neurohormonal activation in patients with incident heart failure: serial changes and prognostic value.
    Mikkelsen KV; Møller JE; Bie P; Ryde H; Videbaek L; Haghfelt T
    Eur J Heart Fail; 2006 Oct; 8(6):599-608. PubMed ID: 16469536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
    Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
    Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
    J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.
    Mikkelsen KV; Bie P; Møller JE; Videbaek L; Villadsen HD; Haghfelt T
    Int J Cardiol; 2006 Jun; 110(3):324-33. PubMed ID: 16213609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implication of N-terminal pro-B-type natriuretic peptide and Tei index of left ventricle changes in children with ventricular septal defect treated by transcatheter interventional therapy].
    Wu RZ; Zhang SY; Xia TH; He YE; Chen Q; Xiang RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):325-8. PubMed ID: 21624308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy.
    Stämpfli SF; Erhart L; Hagenbuch N; Stähli BE; Gruner C; Greutmann M; Niemann M; Kaufmann BA; Jenni R; Held L; Tanner FC
    Int J Cardiol; 2017 Jun; 236():321-327. PubMed ID: 28268080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
    Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
    Tschöpe C; Kasner M; Westermann D; Gaub R; Poller WC; Schultheiss HP
    Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary NT-proBNP level: relationship with ventricular function parameters in heart failure].
    Roselló-Lletí E; Rivera M; Miró V; Mora V; Cortés R; Lauwers C; Valero R; Sevilla B; Sogorb F; Morillas P; García de Burgos F; Portolés M
    Rev Esp Cardiol; 2007 May; 60(5):510-6. PubMed ID: 17535762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
    Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial.
    Luchner A; Weidemann A; Willenbrock R; Philipp S; Heinicke N; Rambausek M; Mehdorn U; Frankenberger B; Heid IM; Eckardt KU; Holmer SR
    Clin Chem Lab Med; 2010; 48(1):121-8. PubMed ID: 20047532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
    Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.